Vitec Software Group AB (publ) (VIT-B)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 300.40 |
|---|---|
| 52-week range | 211.26 – 377.48 |
| Return, 1 month / 3 months | +16.8% / +37.4% |
| Return, 1 year / 3 years | −18.5% / −35.7% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 39.3% |
| Worst drawdown (1 year) | -41.2% |
| Average daily value traded | 24.12M SEK |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vitec Software Group is a Swedish software company based in Umeå that develops and acquires vertical market software. Its products serve the specific needs of niche industries, including healthcare, education, real estate, manufacturing and the public sector. Customers are organisations that need specialised business systems rather than general-purpose software, and the company operates through a group of subsidiary businesses, each focused on its own industry segment and local market.
Vitec Software Group AB (publ) trades under the code VIT-B on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vitec Software Group AB (publ) (VIT-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 300.40 on 19 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 215 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.5% and over the last three months it rose 37.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 20.1% | ||
| From 52-week high | -16.9% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 37.4% | ||
| 6-month return | 8.6% | ||
| 12-month return, skipping the last month | -30.3% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 39.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.2% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 24.12M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +5.2% |
|---|---|
| 1 month | +16.8% |
| 3 months | +37.4% |
| 6 months | +8.6% |
| 1 year | −18.5% |
| 3 years | −35.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 265.22 / 250.11 |
|---|---|
| Golden / death cross (60 days) | Golden, 13 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Sep 2026 | SEK 0.9200 |
| 24 Jun 2026 | SEK 0.9200 |
| 24 Mar 2026 | SEK 0.9000 |
| 19 Dec 2025 | SEK 0.9000 |
| 23 Sep 2025 | SEK 0.9000 |
| 24 Jun 2025 | SEK 0.9000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.